SC Condemns Witch-Hunting, Says Superstition Continues to Override Constitutional Morality  ||  SC: Retired Judges Appointed to Central Industrial Tribunals Not Entitled to Pay Parity  ||  SC: Electricity Boards Liable for Electrocution Deaths under Strict, Not Absolute Liability  ||  Supreme Court Criticizes Courts For Conducting ‘Mini-Trials’ in Temporary Injunction Matters  ||  SC: Common Judgment in Suits by Same Plaintiff can be Challenged Through Composite Appeal  ||  Chandigarh Court Orders Meta to Take Down AI-Generated Video of Punjab MLA Sukhpal Khaira  ||  Delhi HC: Insolvency Professionals Must Collect & Deposit GST Even if they are Advocates  ||  Madras HC Rejects Election Petition Challenging Colachel MLA Tharahai Cuthbert  ||  Supreme Court: Uncrystallized Contractual Damages Not an Operational Debt under Section 9 IBC  ||  Supreme Court: Interest Accrued in Suspense Account After NPA Classification is Recoverable as Debt    

National Pharmaceutical Pricing Authority Notifies All Medical Devices Under Price Control - (02 Apr 2020)

LAW OF MEDICINE

National Pharmaceutical Pricing Authority has notified all medical devices sold in India as ‘drugs’ to bring the devices — such as syringes, needles, cardiac stents, a knee implant, digital thermometers, CT scan, MRIs and dialysis machines — under the purview of price control and prohibit firms from hiking their costs by more than 10% annually at a time.

Tags : NATIONAL PHARMACEUTICAL PRICING AUTHORITY   ALL MEDICAL DEVICES UNDER PRICE CONTROL  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved